drug-drug interaction
Showing 9976 - 10000 of >10,000
COVID-19 INfection on Blood Vessels And Blood pRessure
Recruiting
- Hypertension
- Covid19
- Cases
- Controls
-
Glasgow, United KingdomProfessor Sandosh Padmanabhan
Apr 26, 2022
Mycosis Fungoides Trial in Edmonton (Cemiplimab)
Not yet recruiting
- Mycosis Fungoides
-
Edmonton, Alberta, CanadaCross Cancer Institute
Sep 12, 2022
Bioequivalence Trial in Hanoi (FABALOFEN 60, JAPROLOX TABLET)
Completed
- Bioequivalence
- FABALOFEN 60
- JAPROLOX TABLET
-
Hanoi, VietnamCentre of Clinical Pharmacology, Hanoi Medical University
Mar 17, 2021
Angina, Stable Trial in Chengdu (acupuncture, Basic treatment)
Completed
- Angina, Stable
- acupuncture
- Basic treatment
-
Chengdu, Sichuan, ChinaChengdu University of Traditional Chinese Medicine
Feb 13, 2020
Autism Spectrum Disorder Trial in Taipei (Telehealth Early Intervention Program (TEIP))
Recruiting
- Autism Spectrum Disorder
- Telehealth Early Intervention Program (TEIP)
-
Taipei, TaiwanSchool and Graduate Institute of Physical Therapy
Mar 31, 2023
Bacterial Infection Trial in Knoxville (Apramycin (EBL-1003))
Not yet recruiting
- Bacterial Infection
- Apramycin (EBL-1003)
-
Knoxville, TennesseeAlliance for Multispecialty Research, LLC - Knoxville
Feb 2, 2023
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +3 more
- Biopsy
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 9, 2023
Postsurgical Pain Trial in Ukraine (Ketorolac tromethamine, solution for injection then Neospastil, film-coated tablets,
Completed
- Postsurgical Pain
- Ketorolac tromethamine, solution for injection then Neospastil, film-coated tablets
- +2 more
-
Chernivtsi, Ukraine
- +13 more
Nov 1, 2022
MDD Trial in Hangzhou (SSRI, SIA, AIA)
Recruiting
- Major Depressive Disorder
- SSRI
- +2 more
-
Hangzhou, Zhejiang, Chinathe Third affiliated hospital of Zhejiang Chinese Medical univer
Jan 31, 2023
Famotidine in Covid-19 Intensive Care Unit
Completed
- COVID-19 Pandemic
- Famotidine Tablets
-
İ̇stanbul, TurkeyIstanbul Medeniyet University
Apr 12, 2022
Advanced Solid Tumor Trial in Beijing (HS-20093 (Phase Ia: Dose escalation), HS-20093 (Phase Ib: Dose expansion))
Recruiting
- Advanced Solid Tumor
- HS-20093 (Phase Ia: Dose escalation)
- HS-20093 (Phase Ib: Dose expansion)
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Mar 1, 2022
Salivary Cancer Trial in United States (enzalutamide)
Active, not recruiting
- Salivary Cancer
-
Anchorage, Alaska
- +286 more
Oct 6, 2021
Sjogren's Syndrome (SS) Trial in Utrecht (Ravaglimab, Ravagalimab, Placebo)
Withdrawn
- Sjogren's Syndrome (SS)
- Ravaglimab
- +2 more
-
Utrecht, NetherlandsUniversitair Medisch Centrum Utrecht /ID# 214029
Jan 20, 2022
Multiple Sclerosis Trial in Worldwide (ofatumumab with PRF, ofatumumab with AI)
Completed
- Multiple Sclerosis
- ofatumumab with PRF
- ofatumumab with AI
-
Fullerton, California
- +40 more
Oct 7, 2021
A Prospective Clinical Study of Phenylketonuria (PKU)
Active, not recruiting
- Phenylketonurias
-
Aurora, Colorado
- +13 more
Jan 28, 2022
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8 Trial in United States (drug,
Recruiting
- Lung Non-Small Cell Carcinoma
- +2 more
- Atezolizumab
- +4 more
-
Anchorage, Alaska
- +308 more
Feb 2, 2023
Heart Failure, Inflammation Trial in Dallas (Low Dose Colchicine, Placebo)
Not yet recruiting
- Heart Failure
- Inflammation
- Low Dose Colchicine
- Placebo
-
Dallas, TexasUT Southwestern Medical Center
Nov 11, 2023
Pharmacokinetics, Healthy Volunteers Trial in Brussels (Rosuvastatin, Nirmatrelvir/ritonavir)
Not yet recruiting
- Pharmacokinetics
- Healthy Volunteers
-
Brussels, Bruxelles-capitale, Région DE, BelgiumBrussels Clinical Research Unit
Jun 1, 2023
Castration-Resistant Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Trial in Buffalo
Recruiting
- Castration-Resistant Prostate Carcinoma
- +3 more
- Decitabine and Cedazuridine
- Enzalutamide
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 27, 2022